This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human BIRC7 / Livin Protein (Recombinant His) - LS-G20010
catalog :
LS-G20010
product information
ProteinId :
20010
CatalogNumber :
LS-G20010
Product Name :
Human BIRC7 / Livin Protein (Recombinant His) - LS-G20010
Description :
BIRC7 Human Recombinant fused to N-terminal His-Tag produced in E.Coli is a single, non-glycosylated polypeptide chain containing 318 amino acids and having a molecular mass of 34 kDa.
PresentationDesc :
20 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 2 mM EDTA, 20% glycerol, 1 mM DTT
ProteinTag :
His
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
E. coli
RecommendedStorage :
Store at 4°C short term. Store at -20°C long term. Carrier protein recommended for long term storage or low concentration. Avoid multiple freeze-thaw cycles
Purification :
Greater than 90% by SDS-PAGE and RP-HPLC
PredictedMolecularWeight :
34.0 kDa
Gene :
BIRC7 / Livin
StandardGeneSymbol :
BIRC7
gene family :
Apoptosis
Synonyms :
BIRC7, KIAP, Livin inhibitor of apoptosis, MLIAP, ML-IAP, RNF50, RING finger protein 50, LIVIN
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.